- Home
- TECH
TECH
Bio-Techne Corp
as 11-20-2024 4:00pm EST
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
| Founded: | 1976 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 11.3B | IPO Year: | 1989 |
| Target Price: | $81.78 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.95 | EPS Growth: | -37.52 |
| 52 Week Low/High: | $61.16 - $85.57 | Next Earning Date: | 10-30-2024 |
| Revenue: | $1,171,583,000 | Revenue Growth: | 2.41% |
| Revenue Growth (this year): | 7.67% | Revenue Growth (next year): | 9.38% |
Latest Bio-Techne Corp News
TECH Breaking Stock News: Dive into TECH Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
Bio-Techne Signs Distribution Deal With Leader Life Sciences
PR Newswire
a day ago
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
PR Newswire
3 days ago
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
Morningstar Research
6 days ago
Analyst Report: Bio-Techne Corporation
PR Newswire
7 days ago
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
PR Newswire
10 days ago
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
PR Newswire
10 days ago
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
PR Newswire
13 days ago
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
Compare TECH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TECH Bio-Techne Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.